Comparison of risk factors for contrast‐induced acute kidney injury between patients with and without diabetes
- 27 August 2010
- journal article
- research article
- Published by Wiley in Hemodialysis International
- Vol. 14 (4) , 387-392
Abstract
Although it is well known that diabetics are at a higher risk of contrast‐induced acute kidney injury (CI‐AKI) than nondiabetic patients, the reason for this discrepancy is not well known. Thus, in this study, we compared the predisposing factors for CI‐AKI between patients with and without diabetes. We prospectively studied 290 consecutive in‐hospital patients including 88 diabetics undergoing coronary angiography or a percutaneous coronary intervention in Kowsar hospital, and we compared risk factors for CI‐AKI between diabetic and nondiabetic patients. CI‐AKI was defined as RIFLE criteria within 48 hours after contrast exposure. The incidence of CR‐AKI was significantly higher in diabetic patients compared with nondiabetics (P<0.05). The incidence of CI‐AKI was significantly higher in patients with diabetes and left‐ventricular ejection fraction ≤40%, hypercholesterolemia, serum creatinine ≥1.1 mg/dL, estimated glomerular filtration rate (eGFR) <90 mL/min, Contrast volume ≥80 (mL), maximum safe contrast volume factor of 1.5, and dehydration, while in nondiabetics, a significantly higher incidence of CR‐AKI was observed in those with serum creatinine ≥1.1 mg/dL (P=0.02) and/or eGFR<60 mL/min (P=0.01). Multiple logistic regression analysis showed hyperchlosteremia to be the strongest predictor of AKI (P=0.01, B:14.5) in diabetics, followed by eGFR<90 (P=0.05, B:12.4) but, in nondiabetics, only eGFR<60 predicted the occurrence of CI‐AKI (P=0.04, B:2.3). It seems that the predisposing factors to CI‐AKI differ in diabetics and nondiabetics. In patients with diabetes, hypercholesterolemia is the strongest predictor of CI‐AKI, followed by eGFR and diabetics are at risk for CI‐AKI in the early stage of chronic kidney disease (stage 2), accounting for the higher incidence of CI‐AKI in them.Keywords
This publication has 24 references indexed in Scilit:
- A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trialInternational Urology and Nephrology, 2009
- Serious renal dysfunction after percutaneous coronary interventions can be predictedAmerican Heart Journal, 2008
- Risk Prediction of Contrast-Induced NephropathyThe American Journal of Cardiology, 2006
- Risk Factors for Contrast-Induced NephropathyKidney and Blood Pressure Research, 2006
- Assessing Kidney Function — Measured and Estimated Glomerular Filtration RateNew England Journal of Medicine, 2006
- Follow-up of patients with contrast-induced nephropathyKidney International, 2006
- Contrast Material‐Induced Renal Failure: An OverviewJournal of Interventional Cardiology, 2005
- Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the artNephrology Dialysis Transplantation, 2005
- Pathophysiology of contrast medium–induced nephropathyKidney International, 2005
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001